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Objectives: In CF patients, upper airways are a site of ﬁrst and persistent infection
with pathogens like P. aeruginosa as they reveal the same epithelial CFTR defect
as the lower respiratory tract. However, CF sinonasal inﬂammation and host
defense mechanisms are poorly understood. Whereas systemic antibiotic treatment
is highly effective to reduce pulmonary pathogen-related inﬂammation, its effects
on sinonasal inﬂammation are unknown. Therefore, we assessed effects of systemic
antibiotics on sinonasal inﬂammatory markers and compared results to nasal lavage
ﬁndings from a healthy control group.
Methods: Nasal Lavage Fluid (NLF, 10ml per nasal side) from 17 CF patients
was collected prior and during intravenous antibiotic treatment. Microbiology and
cytology were assessed. Cytokine expression was measured by Cytometric Bead
Arrays and ELISA (IL-1b/IL-6/IL-8/MPO/MMP9/RANTES/TNF/PMNE). Findings
were compared to 52 healthy controls.
Results: In comparison to healthy controls, detection frequency of MPO, IL-8, IL-6,
IL-1b, TNF and NLF cell count were signiﬁcantly higher in CF patients. During
intravenous therapy, sinonasal IL-6 levels decreased signiﬁcantly (p = 0.0059), NLF
cell count decreased, and RANTES levels and MMP9 levels declined 10fold and
2fold, respectively in CF patients.
PMNE was detected for the ﬁrst time in NLF, revealing no signiﬁcant changes
during AB treatment.
Conclusions: Analysis of NLF inﬂammatory markers reveals considerable differ-
ences among controls and CF patients prior and during treatment. Collection of
epithelial surface liquid from the upper airways is a promising diagnostic and
scientiﬁc tool.
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Background: Cystic ﬁbrosis (CF) is caused by mutations in the CF transmembrane
conductance regulator (CFTR) gene and is characterized by a chronic progressive
airway inﬂammation and infection with opportunistic bacteria like Pseudomonas
aeruginosa (PSA). Studies have revealed an dysregulation of T cell subpopulations
favoring Th17 and Th2 phenotypes in CF patients. Therefore, regulatory T cells
(Treg cells) might play a pathophysiologic role in CF. In this study we aimed to
dissect the function of Treg cells in CF.
Methods: CD4+CD25+Foxp3+ Treg cells were assessed in blood samples from
CF patients with or without PSA infection, from healthy controls and from Cftr−/−
mice versus wild type mice via ﬂow cytometry. To investigate the effect of CFTR
and PSA on Treg cells, we treated peripheral blood mononuclear cells (PBMCs)
with CFTR inhibitors and supernatants of different PSA strains.
Results: The percentages of CD4+CD25+Foxp3+ cells were signiﬁcantly lower in
CF patients and Cftr−/− mice compared to healthy controls and wild type mice,
respectively. Within the CF patients, those chronically infected by PSA showed
signiﬁcantly decreased numbers of Treg cells compared to those intermittently
infected with or free of PSA. In vitro treatment of PBMCs with CFTR inhibitors or
supernatant of PSA strains resulted in diminished fraction of CD4+CD25+Foxp3+
cells.
Conclusion: The reduction of Treg cells might be a cause for the T cell imbalance
previously described in CF patients and may therefore play a signiﬁcant role in the
pathophysiology in CF disease.
